From Scourge to Cure: Tumour-Selective Viral Pathogenesis as a New Strategy against Cancer. PLoS Pathog. 2014, 10, e1003836. [Google Scholar] [CrossRef] [Green Version] Raman, S.S.; Hecht, J.R.; Chan, E. Talimogene laherparepvec: Review of its mechanism of action and clinical ...
Food and Drug Administration (FDA)-approved for the treatment of HSV infection and HSV encephalitis, with high cure rates. However, long-term use of ACV often results in serious side effects and the emergence of drug-resistant virus strains. In addition, these nucleoside analogs are not ...